The enrolment will lead to second $50m milestone payment obligation to Pharmacyclics from Janssen Biotech, a worldwide collaborator on ibrutinib in oncology and sponsor of the MCL trial.
As part of the agreement, United Drug will acquire Bilcare’s Global Clinical Supplies (GCS) business in UK and US for $61m. The agreement will enable Bilcare GCS Asia
As per the agreement, Fina will earn upfront payment, payments based on achievement of Chinese regulatory milestones, and royalty payments that are contingent upon successful development and commercialization.
The RapidHIT System automates and accelerates the process of producing standardized DNA profiles from cheek swabs and other human samples in about 90 minutes, according to IntegenX. IntegenX
Xopenex inhalation solution indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children six years of age and older with reversible obstructive airway disease, has
Version 13.0 adds improvements to the ChemBioDraw and ChemBio3D modules while providing secure cloud storage for improved data sharing. The ChemBioOffice suite helps chemists and biologists to track
Sklice Lotion in its third phase clinical trials could treat most head lice infestations with ten minute application. Majority of the patients treated with Sklice Lotion for a
Avid’s major products include Vitafusion, an adult gummy vitamin and L’il Critters, children’s gummy vitamin. Church & Dwight chairman and chief executive officer James Craigie said the acquisition
Pioglitazone hydrochloride tablet is an oral antidiabetic agent, which acts by decreasing insulin resistance and is currently distributed by Takeda Pharmaceuticals America under the name Actos. The product
The study is designed to recruit 40 patients at four different US sites and provide top-line data by mid-2013 calendar year. Oculus Innovative’s dermatology partner, AmDerma/Quinnova, has agreed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.